BEUDAMED
    515 results · 28ms · Sources: EU EUDAMED, US FDA
    Filters Classification: FDA Class 2 ×

    AUTOLINK BODY PLETHYSMOGRAPH

    FDA 510(k)
    FDA Class 2 ·Anesthesiology

    OXYLOG 2

    FDA 510(k)
    FDA Class 2 ·Anesthesiology

    TRANSFLOW TEST

    FDA 510(k)
    FDA Class 2 ·Anesthesiology

    PARAPAC

    FDA 510(k)
    FDA Class 2 ·Anesthesiology

    BENCHMARK TRANSFER TEST

    FDA 510(k)
    FDA Class 2 ·Anesthesiology

    MODEL #535 PACU STRETCHER/BED & #530 ED/TRAUMA STR

    FDA 510(k)
    FDA Class 2 ·General Hospital

    Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus

    FDA Pre-Market Approval
    FDA Class 2 ·APTIMA HCV RNA QUALITATIVE ASSAY

    Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus

    FDA Pre-Market Approval
    FDA Class 2 ·Aptima HCV RNA Qualitative Assay

    Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus

    FDA Pre-Market Approval
    FDA Class 2 ·Aptima HCV RNA Qualitative Assay

    Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus

    FDA Pre-Market Approval
    FDA Class 2 ·Aptima HCV RNA Qualitative Assay

    Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus

    FDA Pre-Market Approval
    FDA Class 2 ·VERSANT HCV RNA QUALITATIVE ASSAY

    Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus

    FDA Pre-Market Approval
    FDA Class 2 ·APTIMA HCV RNA QUALITATIVE ASSAY

    Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus

    FDA Pre-Market Approval
    FDA Class 2 ·VERSANT HCV RNA QUALITATIVE ASSAY/APTIMA HCV RNA QUALITATIVE ASSAY

    Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus

    FDA Pre-Market Approval
    FDA Class 2 ·Aptima HCV RNA Qualitative Assay

    Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus

    FDA Pre-Market Approval
    FDA Class 2 ·VERSANT HCV RNA QUALITATIVE ASSAY/APTIMA HCV RNA QUALITATIVE ASSAY

    Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus

    FDA Pre-Market Approval
    FDA Class 2 ·VERSANT & APTIMA HCV RNA QUALITATIVE ASSAY

    Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus

    FDA Pre-Market Approval
    FDA Class 2 ·Aptima HCV RNA Qualitative Assay

    Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus

    FDA Pre-Market Approval
    FDA Class 2 ·APTIMA HCV RNA QUALITATIVE ASSAY

    Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus

    FDA Pre-Market Approval
    FDA Class 2 ·VERSANT HCV RNA QUALITATIVE ASSAY

    Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus

    FDA Pre-Market Approval
    FDA Class 2 ·VERSANT HCV RNA QUALITATIVE ASSAY/APTIMA HCV RNA QUALITATIVE ASSAY